About us
- >
- About us >
- Information >
- Announcement
2019-08-19
The phase II trial of ENERGI-F701 solution for female hair loss treatment has achieved the goal of target patient enrollment.
With the approval of FDA and TFDA, the phase II trial of ENERGI-F701 solution for female hair loss treatment has achieved the goal of target patient enrollment on 19th of Aug, 2019. The clinical trial will evaluate the efficacy of ENERGI-F701 solution in subjects with female hair loss.